mitoxantrone has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 3 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma: A leukemia/lymphoma found predominately in children and young adults and characterized LYMPHADENOPATHY and THYMUS GLAND involvement. It most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.
Excerpt | Relevance | Reference |
---|---|---|
" Clofarabine dosed at 52 mg/m2 was used in adult patients with refractory ALL to maximize response before allo-HSCT." | 2.45 | The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia. ( Brown, AW; McGregor, BA; Osswald, MB; Savona, MR, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jang, W | 1 |
Kim, M | 1 |
Lee, JW | 1 |
Chung, NG | 1 |
Deenik, W | 1 |
Beverloo, HB | 1 |
van der Poel-van de Luytgaarde, SC | 1 |
Wattel, MM | 1 |
van Esser, JW | 1 |
Valk, PJ | 1 |
Cornelissen, JJ | 1 |
McGregor, BA | 1 |
Brown, AW | 1 |
Osswald, MB | 1 |
Savona, MR | 1 |
1 review available for mitoxantrone and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2009 |
2 other studies available for mitoxantrone and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; | 2014 |
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Combined Modality Therapy; Cytarabine; | 2009 |